Frank Y Ma Selected Research

Frank Y Ma Research Topics

Disease

21	Fibrosis (Cirrhosis) 01/2021 - 02/2007
10	Inflammation (Inflammations) 01/2021 - 11/2007
8	Kidney Diseases (Kidney Disease) 10/2020 - 01/2011
8	Glomerulonephritis 02/2018 - 04/2009
7	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2010
5	Proteinuria 10/2018 - 04/2009
3	Chronic Renal Insufficiency 12/2020 - 01/2016
3	Diabetic Nephropathies (Diabetic Nephropathy) 10/2018 - 11/2015
3	Thrombosis (Thrombus) 01/2018 - 12/2011
3	Nephritis 01/2018 - 12/2011
3	Albuminuria 11/2015 - 01/2011
2	Balkan Nephropathy (Balkan Endemic Nephropathy) 10/2021 - 01/2021
2	Reperfusion Injury 01/2021 - 01/2016
2	Necrosis 12/2020 - 09/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2018 - 01/2016
2	Emphysema 02/2018 - 05/2012
2	Disease Progression 01/2016 - 04/2009
1	Renal Insufficiency (Renal Failure) 01/2021
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 02/2018
1	Rupture 02/2018
1	Rheumatoid Arthritis 01/2016
1	Hypertension (High Blood Pressure) 11/2015
1	Hypertrophy 01/2011
1	Delayed Graft Function 09/2010
1	Ureteral Obstruction 02/2007

Drug/Important Bio-Agent (IBA)

10	Phosphotransferases (Kinase)IBA 01/2021 - 01/2009
9	p38 Mitogen-Activated Protein KinasesIBA 10/2020 - 11/2007
7	JNK Mitogen-Activated Protein KinasesIBA 01/2022 - 02/2007
6	CollagenIBA 01/2018 - 02/2007
5	Syk KinaseIBA 01/2018 - 12/2011
4	EnzymesIBA 02/2018 - 06/2011
4	Matrix Metalloproteinases (MMPs)IBA 02/2018 - 12/2011
4	antiglomerular basement membrane antibodyIBA 02/2018 - 04/2009
4	Messenger RNA (mRNA)IBA 05/2012 - 11/2007
3	aristolochic acid I (aristolochic acid)IBA 01/2022 - 01/2021
3	4- (9- (tetrahydrofuran- 3- yl))- 8- (2,4,6- trifluorophenylamino)- 9H- purin- 2- ylaminocyclohexan- 1- olIBA 01/2021 - 01/2011
3	MAP Kinase Kinase Kinase 5IBA 10/2020 - 01/2016
3	GS-444217IBA 10/2018 - 11/2015
3	CC 401IBA 09/2010 - 02/2007
2	Cyclophilin AIBA 12/2020 - 05/2020
2	Cyclophilins (Cyclophilin)IBA 12/2020 - 01/2018
2	Extracellular Matrix ProteinsIBA 02/2018 - 05/2012
1	CalcineurinIBA 12/2020
1	InterleukinsIBA 09/2019
1	ChemokinesIBA 09/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2019
1	Fibronectins (Fibronectin)IBA 09/2019
1	LigandsIBA 09/2019
1	PAR-2 ReceptorIBA 09/2019
1	Enalapril FDA LinkGeneric 10/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2018
1	Pancreatic Elastase (Elastase)IBA 02/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 02/2016
1	Mineralocorticoid Receptor AntagonistsIBA 01/2015
1	BR-4628IBA 01/2015
1	Cystatin CIBA 10/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2014
1	Matrix Metalloproteinase 12IBA 10/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2014
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2014
1	Immunoglobulin G (IgG)IBA 12/2013
1	Plasminogen Activator Inhibitor 1IBA 05/2012
1	FibrinIBA 12/2011
1	P-SelectinIBA 12/2011
1	Macrophage Colony-Stimulating FactorIBA 07/2011
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 06/2011
1	Transcription Factors (Transcription Factor)IBA 06/2011
1	NPHS2 proteinIBA 01/2011
1	nephrinIBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2009
1	MitogensIBA 01/2009
1	Mitogen-Activated Protein KinasesIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	Protein Isoforms (Isoforms)IBA 02/2007

Therapy/Procedure

1	Therapeutics 01/2015
1	Kidney Transplantation 09/2010